 bifurcation in select
groups of neurologically asymptomatic patients are
controversial.3 Although statistically signiﬁcant in large
trials including the Asymptomatic Carotid Atherosclerosis Study (ACAS),28 the beneﬁt of CEA and other carotid
stenting interventions in preventing stroke in asymptomatic patients is much lower than among neurologically
symptomatic individuals. Moreover, the magnitude of
beneﬁt depends on